| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/07/1994 | EP0478609B1 Srif-related peptides and uses thereof |
| 09/07/1994 | EP0462210B1 Vaccines for nontypable haemophilus influenzae |
| 09/07/1994 | CN1091775A Marmoset zona pellucida protein ZP3 |
| 09/07/1994 | CN1091773A Recombinant mutant pastaurella multocida protein, process for preparing same, DNA sequence encoding the protein, replicon comprising the DNA sequence and cells transformed with such replicon |
| 09/07/1994 | CN1025860C Cross reactive and protective epitope of cicumsporozoite proteins |
| 09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 09/06/1994 | US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome |
| 09/06/1994 | US5344755 Method for detecting immune system dysfunction in asymptomatic, HIV-scropositive individuals |
| 09/06/1994 | US5344645 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/01/1994 | WO1994019697A1 Methods of inducing immunity to lyme disease and a colorimetric assay for borreliacidal activity of antisera |
| 09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | WO1994019482A1 Heterologous antigens in live cell vaccine strains |
| 09/01/1994 | WO1994019478A1 Production of high titer helper-free retroviruses by transient transfection |
| 09/01/1994 | WO1994019470A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 09/01/1994 | WO1994019466A2 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | WO1994019457A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 09/01/1994 | WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/01/1994 | WO1994019015A1 Recombinant fowlpox viruses and uses thereof |
| 09/01/1994 | WO1994019014A1 Recombinant fowlpox virus s-fpv-043 and uses thereof |
| 09/01/1994 | WO1994019013A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| 09/01/1994 | WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | WO1994019010A1 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity |
| 09/01/1994 | WO1994018998A1 Treatment of allergic responses using mhc-peptide complexes |
| 09/01/1994 | WO1994018997A1 Method of enhancing immune response to oral vaccines |
| 09/01/1994 | WO1994018995A1 Allogeneic vaccine and method to synthesize same |
| 09/01/1994 | WO1994018991A1 EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b) |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
| 09/01/1994 | WO1994018950A1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients |
| 09/01/1994 | WO1994010194A3 Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the fagales order |
| 09/01/1994 | WO1994000152A1 Papillomavirus vaccines |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2594184A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | CA2157125A1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients |
| 09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | CA2157004A1 Methods of inducing immunity to lyme disease and a colorimetric assay for borreliacidal activity of antisera |
| 09/01/1994 | CA2156859A1 Method of enhancing immune response to oral vaccines |
| 09/01/1994 | CA2156725A1 Production of high titer helper-free retroviruses by transient transfection |
| 09/01/1994 | CA2156525A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| 09/01/1994 | CA2156423A1 Recombinant fowlpox viruses and uses thereof |
| 09/01/1994 | CA2156191A1 Heterologous antigens in live cell vaccine strains |
| 09/01/1994 | CA2155934A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/01/1994 | CA2155515A1 Expansion of stem cells in long term bone marrow cultures by neutralization of tgf-.beta. |
| 09/01/1994 | CA2155119A1 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity |
| 08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
| 08/31/1994 | EP0612845A2 Purified opioid receptor |
| 08/31/1994 | EP0612844A2 Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same |
| 08/31/1994 | EP0612532A2 Canine coronavirus vaccine from feline enteric coronavirus |
| 08/31/1994 | EP0612525A1 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| 08/31/1994 | EP0612355A1 Detection of human p58 protein kinase and its dna for diagnosis of certain cancers |
| 08/31/1994 | EP0612353A1 Detection method for c-raf-1 genes |
| 08/31/1994 | EP0612251A1 Stabilised antibodies |
| 08/31/1994 | EP0612244A1 Endothelin receptor antagonists |
| 08/31/1994 | CN1091294A BCG vaccine tablet |
| 08/30/1994 | US5342977 Aminosulfonic acid derivatives and processes for their preparation |
| 08/30/1994 | US5342930 Genetic engineering |
| 08/30/1994 | US5342924 Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor |
| 08/30/1994 | US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| 08/30/1994 | US5342761 Oncofetal gene, gene product and uses therefor |
| 08/30/1994 | US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
| 08/30/1994 | CA1331738C Method and formulation for orally administering bioactive agents to and through the peyer's patch |
| 08/26/1994 | CA2116253A1 Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same |
| 08/26/1994 | CA2115404A1 Tumor suppressor gene merlin and uses thereof |
| 08/26/1994 | CA2114968A1 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| 08/25/1994 | DE4337197C1 Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours |
| 08/24/1994 | EP0611822A2 More complex type retroviruses having mixed type LTR, and uses thereof |
| 08/24/1994 | EP0611571A1 Teicoplanin containing topical compositions with delayed release of the active agent |
| 08/24/1994 | EP0611397A1 Feline leukemia virus vaccines |
| 08/24/1994 | EP0611394A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 08/24/1994 | EP0611304A1 Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/24/1994 | CN1091139A PTP-D subfamily of protein tyrosine phosphatases |
| 08/24/1994 | CN1091138A Vaccines |
| 08/23/1994 | USRE34705 Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby |
| 08/23/1994 | US5340923 Methods for making and purifying antivenoms |
| 08/23/1994 | US5340922 Polypeptide |
| 08/23/1994 | US5340921 Γ, δT cell receptor and methods and detection |
| 08/23/1994 | US5340731 Method of preparing a B-1,4 glycan matrix containing a bound fusion protein |
| 08/23/1994 | US5340720 Detecting RNA polymerase I antibody in urine sample |
| 08/23/1994 | US5340575 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
| 08/23/1994 | CA1331562C Vaccine |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994018560A1 Method of assaying human tau protein, kit therefor, and diagnostic method |
| 08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | WO1994018325A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 08/18/1994 | WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 08/18/1994 | WO1994018311A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 08/18/1994 | WO1994018309A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | WO1994018234A1 Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains |
| 08/18/1994 | WO1994018232A1 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| 08/18/1994 | WO1994018222A1 Nuclear matrix proteins |
| 08/18/1994 | WO1994018217A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 08/18/1994 | WO1994018151A1 Acylfulvene analogues as antitumor agents |
| 08/18/1994 | WO1994017831A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/18/1994 | WO1994017828A2 Treatment for insulin dependent diabetes |
| 08/18/1994 | WO1994017827A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | WO1994017826A1 Vaccinal polypeptides |
| 08/18/1994 | WO1994017825A1 Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use |
| 08/18/1994 | WO1994017824A1 Carbohydrate-based vaccine and diagnostic reagent for trichinosis |